NAFLD and T2D: A genetic or metabolic issue?

被引：3
|
作者：
Carulli, L. [1 ]
Rondinella, S. [1 ]
Rudilosso, A. [1 ]
Ganazzi, D. [1 ]
Bertolotti, M. [1 ]
Loria, P. [1 ]
Carulli, N. [1 ]
机构：
[1] NOCSAE, Dept Med Endocrinol Metab & Geriatr, Modena, Italy
来源：
JOURNAL OF HEPATOLOGY | 2008年 / 48卷
关键词：
D O I：
10.1016/S0168-8278(08)60909-5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
907
引用
收藏
页码：S340 / S340
页数：1
相关论文
共 50 条
  • [41] Management of Hypertension and Hyperlipidemia in Youth with T2D
    Beaulieu, Lindsey C.
    Cheng, Peiyao
    Katz, Michelle
    Laffel, Lori M.
    Tamborlane, William V.
    Van Name, Michelle A.
    Bansal, Nidhi
    Kollman, Craig
    Gal, Robin L.
    DIABETES, 2018, 67
  • [42] Pancreatic transplantation for patients with T2D and ESRD
    Stratta, R.
    XENOTRANSPLANTATION, 2009, 16 (05) : 304 - 305
  • [43] The repealed HAS T2D 2006 recommendations
    Derrien, Elisa
    ACTUALITES PHARMACEUTIQUES, 2011, 50 (507): : 8 - 8
  • [44] Association of T2D Subgroups with MCI/Dementia
    Bancks, Michael
    Lovato, James
    Balasubramanyam, Ashok
    Coday, Mace
    Johnson, Karen C.
    Munshi, Medha
    Rebello, Candida J.
    Wagenknecht, Lynne E.
    Espeland, Mark
    DIABETES, 2022, 71
  • [45] Dietary Flavonoids in the Prevention of T2D: An Overview
    Alkhalidy, Hana
    Wang, Yao
    Liu, Dongmin
    NUTRIENTS, 2018, 10 (04)
  • [46] Effectiveness of a screening program of type 2 diabetes (T2D) in Primary Care, and long-term incidence of T2D in Spain
    Gabriel, R.
    Vazquez-Fernandez, A.
    Marques, P.
    Novella, B.
    Moreno, S.
    Vega, S.
    Gonzalvez, L.
    Arranz, M.
    Melero, M. C.
    Montero Herrero, M. R.
    Acosta Vergara, T.
    Tuomilehto, J.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 197
  • [47] Non-Alcoholic Fatty Liver Disease (NAFLD) With Type 2 Diabetes (T2D) Have the Lowest Level of Physical Activity
    Mishra, Alita
    Otgonsuren, Munkhzul
    Escheik, Carey
    Stepanova, Maria
    Gerber, Lynn
    Younossi, Zobair M.
    GASTROENTEROLOGY, 2012, 142 (05) : S1019 - S1019
  • [48] Expanding Eligibility for Pediatric T2D Clinical Trials: Insights from the Pediatric Diabetes Consortium (PDC) T2D Registry
    Tamborlane, William V.
    Cheng, Peiyao
    Klingensmith, Georgeanna J.
    Gal, Robin L.
    Kollman, Craig
    Vanname, Michelle
    Bacha, Fida
    Willi, Steven M.
    Beck, Roy W.
    DIABETES, 2017, 66 : A366 - A366
  • [49] Metabolic benefits of adding pioglitazone to patients with Type 2 diabetes (T2D) already optimized on insulin therapy
    Mattoo, V
    Eckland, D
    Widel, M
    Duran, S
    Fajardo, C
    Strand, J
    Knight, D
    Oakley, D
    Tan, M
    DIABETOLOGIA, 2004, 47 : A59 - A59
  • [50] Prevalence of Insomnia (Symptoms) in T2D and Association With Metabolic Parameters and Glycemic Control: Meta-Analysis
    Koopman, Anitra D. M.
    Beulens, Joline W.
    Dijkstra, Tine
    Pouwer, Frans
    Bremmer, Marijke A.
    van Straten, Annemieke
    Rutters, Femke
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (03): : 614 - 643
12345